Physician profile
Julia W Feuer
NPI 1154607984
$1,900.38
in general payments reported to CMS, 2019-2025
15 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $182 · 2023: $880 · 2024: $352 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $310.87 | 2023-2024 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $249.96 | 2024 | Tagrisso, Imfinzi |
| Alkermes, INC. | $221.97 | 2023-2025 | Lybalvi |
| Seagen INC. | $196.41 | 2021 | |
| Almatica Pharma LLC | $160.09 | 2023 | Gralise, Loreev Xr |
| Idorsia Pharmaceuticals US INC | $146.58 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $138.84 | 2023 | Abilify Maintena |
| Exelixis INC. | $135.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Genentech USA, INC. | $55.66 | 2022-2024 | Venclexta, Gazyva |
| Novartis Pharmaceuticals Corporation | $55.05 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $33.78 | 2021 | |
| Karyopharm Therapeutics INC. | $27.78 | 2023 | Xpovio |
| Takeda Pharmaceuticals U.S.A., INC. | $26.39 | 2024 | Ninlaro |
| Tolmar Pharmaceuticals, INC. | $17.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Feuer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.